Lifeboat Foundation

Chemical innovation plays a key role in developing cutting-edge technologies for the military. Research chemists design and synthesize new molecules that could enable a slew of next-generation military products, such as novel propellants for spacecraft engines; new pharmaceuticals and medicines for troops in the field; lighter and longer-lasting batteries and fuel cells; advanced adhesives, coatings and paints; and less expensive explosives that are safer to handle. The problem, however, is that existing molecule design and production methods rely primarily on experts’ intuition in a laborious, trial-and-error research process.

DARPA’s Make-It program, currently in year three of a four-year effort, is developing software tools based on machine learning and expert-encoded rules to recommend synthetic routes (i.e., the “recipe” to make a particular molecule) optimized for factors such as cost, time, safety, or waste reduction. The program seeks to free chemists so that they may focus their energy on chemical innovation, rather than testing various molecular synthesis pathways. The program also is developing automated devices that uniformly and reproducibly create the desired chemical based on the software-generated recipe – this one-device, many-molecules concept is a departure from the traditional dedicated reactors in chemical production. Make-It research teams have recently demonstrated significant progress toward fully automated rapid molecule production, which could speed the pace of chemical discovery for a range of defense products and applications.

“A seasoned research chemist may spend dozens of hours designing synthetic routes to a new molecule and months implementing and optimizing the synthesis in a lab,” said Anne Fischer, program manager in DARPA’s Defense Sciences Office. “Make-It is not only freeing chemists to expend brain power in other areas such as molecular discovery and innovation, it is opening chemical synthesis and discovery to a much broader community of scientific researchers who will benefit from faster development of new molecules.”

An interview with Dr. Vadim Gladyshev, Harvard University.

We have recently had occasion to have a chat with Dr. Vadim Gladyshev, Professor of Medicine and Director of Redox Medicine at Brigham and Women’s Hospital, Harvard Medical School, in Boston, Massachusetts. He is an expert in aging and redox biology and is known for his characterization of the human selenoproteome. His research laboratory focuses on comparative genomics, selenoproteins, redox biology, and, naturally, aging and lifespan control.

Dr. Gladyshev graduated from Moscow State University, in Moscow, Russia; his postdoctoral studies in the 1990s took place at the National Heart, Lung, and Blood Institute, and the National Cancer Institute, in Bethesda, Maryland. Even when he was young, he was very much interested in chemistry and experimental science: he twice won the regional Olympiad in chemistry and graduated from high school with a gold medal. He also graduated with the highest honors from Moscow State University. This enviable track record is even more impressive considering that Dr. Gladyshev completed music school and high school at the same time and became a chess player equivalent to national master during his college years.

Continue reading “Dr. Vadim Gladyshev – Harvard University” »

https://youtube.com/watch?v=doNNClTTYwE

Microsoft is “all-in” on building a quantum computer and is making advancements “every day”, according to one of the company’s top experts on the technology.

Julie Love (above), Director of Quantum Computing, called the firm’s push to build the next generation of computer technology “one of the biggest disruptive bets we have made as a company”.

Continue reading “Microsoft making progress on quantum computer ‘every day’” »

And inflammation is one of the three primary ageing processes.

Scientists have discovered a new metabolic process in the body that can switch off inflammation. They have discovered that ‘itaconate’—a molecule derived from glucose—acts as a powerful off-switch for macrophages, which are the cells in the immune system that lie at the heart of many inflammatory diseases including arthritis, inflammatory bowel disease and heart disease.

The scientists, working in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute at Trinity College Dublin, hope their discovery will have relevance for inflammatory and infectious diseases—and that their findings may also help to develop much-needed new drugs to treat people living with these conditions.

Professor of Biochemistry at Trinity, Luke O’Neill, was, along with Dr. Mike Murphy of the University of Cambridge, the joint leader of the work just published in leading international journal Nature. The discoveries were made using both human cells and mice as a model organism.

Continue reading “Scientists discover promising off-switch for inflammation” »

https://theglowingskinseries.com/day-15/

This could be used for hydrogen storage.

Of the four states of matter, gases are the hardest to pin down. Gas molecules move quickly and wildly and don’t like to be confined. When confined, heat and pressure build in the container, and it doesn’t take long before the gas blows the lid off the place, literally. Luckily, gases are superficial. Provide them with an attractive internal surface area, and they’ll pin themselves down in no time. No, it’s not love at first sight, it’s adsorption.

“Adsorption is the processes of gas pinning to the surface of another material—the inside walls of a container, for example,” says Chris Wilmer, assistant professor in Pitt’s Department of Chemical and Petroleum Engineering. “When adsorption occurs, the gas molecules stop bumping into each other, reducing pressure. So, by increasing a container’s internal surface area, we can store more gas in less space.”

Continue reading “Full of hot air and proud of it” »

A new sodium-ion battery chemistry that shows superior performance to existing state-of-the-art sodium-based batteries could be the catalyst to enabling mass-production of the emerging technology for large-scale energy storage, such as in applications including storing solar power for industrial sites.

Despite sodium’s appeal as a low-cost, abundant and environmentally friendly building block for energy storage, it is a relatively new entrant in the field of battery technology research and development.

A key issue for sodium-ion batteries is that many of the active materials used in their chemistry are sensitive to air—exposure to even a few molecules of air can degrade the material and reduce battery performance.

Viagra reduces colorectal cancer odds in mice by 50%, says a new report which adds that a clinical trial should be the next step.

Summary: Viagra reduces colorectal cancer odds in mice by 50%, says a new report which adds that a clinical trial of low-dose Viagra should be the next step.[This article first appeared on LongevityFacts. Author: Brady Hartman. ]

Viagra cut in half the formation of precancerous polyps that form before the onset of colorectal cancer, says cancer researcher Darren D. Browning Ph.D. – a Professor in the Department of Biochemistry & Molecular Biology and Director of the Biochemistry and Cancer Biology Graduate Program at the Medical College of Georgia (MCG) in Augusta.

Continue reading “Daily Viagra May Reduce Colorectal Cancer Odds” »

Our known universe may end the same way it was created: With a big, sudden bang.

That’s according to new research from a group of Harvard physicists, who found that the destabilization of the Higgs Boson — a tiny quantum particle that gives other particles mass — could lead to a huge explosion of energy that would consume everything in the known universe.

The energy released by the event would destabilize the laws of physics and chemistry.

Continue reading “A second ‘Big Bang’ could end our universe in an instant — and it’s all because of a tiny particle that controls the laws of physics” »